| 期 |
栏目 |
标题 |
文件 |
| 卷 9, 编号 4 (2012) |
Articles |
Iloprost for acute tests in patients with pulmonary arterial hypertension |
|
| 卷 10, 编号 2 (2013) |
Articles |
Legochnaya arterial'naya gipertenziya: na puti ot ratsional'noy diagnostiki k vyboru effektivnoy lekarstvennoy terapii |
|
| 卷 10, 编号 4 (2013) |
Articles |
Riociguatas the first innovative guanylatecyclase stimulators class drugs for pulmonary arterial hypertension patients treatment |
|
| 卷 11, 编号 4 (2014) |
Articles |
The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension |
(Rus)
|
| 卷 12, 编号 2 (2015) |
Articles |
Possibilities of electrocardiographic and decartographic parametersin the diagnosis of right ventricular overload in patients with pulmonary arterial hypertension |
(Rus)
|
| 卷 12, 编号 2 (2015) |
Articles |
Clinical case: combination therapy with iloprost and sildenafil in the treatment of idiopathic pulmonary hypertension |
(Rus)
|
| 卷 12, 编号 2 (2015) |
Articles |
The first results of an international clinical trial VICTORY:the efficacy and safety of antihypertensive valsartan monotherapy and the fixed combination of valsartan and hydrochlorothiazide usingdifferent dosage regimens in patients with 1-2 degree arterial hypertension |
(Rus)
|
| 卷 12, 编号 3 (2015) |
Articles |
Experts of RMSAH opinion: the fixed combination of azilsartan medoxomil and chlortalidone is broadening options of the combined therapyin patients with arterial hypertension |
(Rus)
|
| 卷 12, 编号 3 (2015) |
Articles |
The first Russian experience of sildenafil application in patients with idiopathic pulmonary hypertension |
(Rus)
|
| 卷 12, 编号 4 (2015) |
Articles |
Myocardial ischemia in patients with pulmonary arterial hypertension |
(Rus)
|
| 卷 12, 编号 4 (2015) |
Articles |
Comparison of vectorcardiographic parameters with structural-functional state of the right ventricle in patients with pulmonary hypertension |
(Rus)
|
| 卷 13, 编号 1 (2016) |
Articles |
The validation of the questionnaire for the early detection of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension |
(Rus)
|
| 卷 14, 编号 4 (2017) |
Articles |
Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V |
(Rus)
|
| 卷 14, 编号 3 (2017) |
Articles |
Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Part I |
(Rus)
|
| 卷 15, 编号 1 (2018) |
Articles |
Clinical manual for diagnosis, prevention and treatment of cardiovascular complications of cancer therapy. Parts VI-VII |
(Rus)
|
| 卷 15, 编号 2 (2018) |
Articles |
The influence of antyhypertensive therapy of valsartan and fixed combination with hydrochlorothiazide use on pulse-wave velocity and central arterial pressure in patients with arterial hypertension of 1-2 grades in international VICTORY clinical trial |
(Rus)
|
| 卷 15, 编号 2 (2018) |
Articles |
Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment |
(Rus)
|
| 卷 15, 编号 4 (2018) |
Articles |
Evaluation of effectiveness and safety of the first Russian-manufactured generic bosentan use in patients with pulmonary arterial hypertension |
(Rus)
|
| 卷 6, 编号 1 (2009) |
Articles |
Final results of STRATEGYA Study (Russian Comparative Programme on a fixed,low-dose perindopril/indapamide combination efficacy in hypertensive patients with inadequateblood pressure control): use of a fixed, low- dose perindopril/indapamide combination in hypertensivepatients in real clinical practice |
|
| 卷 16, 编号 2 (2019) |
Articles |
Evaluation of compliance of pulmonary hypertension patients to the treatment with inhaled iloprost (Ventavis): results of prospective, multicenter, non-interventional IVENT study |
(Rus)
|
| 卷 16, 编号 3 (2019) |
Articles |
Clinical, functional and hemodynamic profile of patients with Eisenmenger syndrome in comparison with the group of idiopathic pulmonary hypertension, features of starting specific therapy choice |
(Rus)
|
| 卷 17, 编号 1 (2020) |
Original Article |
Results of pulmonary thromboendarterectomy depending on different levels of pulmonary vascular resistance and angiographic index of the pulmonary artery lesion |
(Rus)
|
| 卷 17, 编号 2 (2020) |
Original Article |
First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension |
(Rus)
|
| 卷 17, 编号 2 (2020) |
Original Article |
Pulmonary hypertension in patients with hemodynamically significant atherosclerotic lesion of a common carotid artery: new pathophysiological mechanisms of the disease |
(Rus)
|
| 卷 17, 编号 2 (2020) |
Review |
Pulmonary hypertension or cardiology aerobatics |
(Rus)
|
| 卷 17, 编号 3 (2020) |
Articles |
Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II |
(Rus)
|
| 卷 18, 编号 1 (2021) |
Original Article |
Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with 2 and 3 grade of arterial hypertension in the Russian clinical study VICTORY II |
(Rus)
|
| 卷 18, 编号 3 (2021) |
Review |
Evaluation of heart rate variability in patients with different forms of pulmonary hypertension |
(Rus)
|
